insights_auto
Zašto je DMYD-B skočio 2,19%?
Istražite detaljnijechevron_right
DMYD-B:STO
Diamyd Medical AB
0,98 SEK
arrow_upward
+2,19%(+0,021) 1D
9. lis, 17:29:56 GMT+2 · SEK
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za DMYD-B...
Otvori
0,95 SEK
Najviša
0,99 SEK
Najniža
0,92 SEK
Trž. kap.
148,45 mil.
Prosj. kol.
759,33 tis.
Količina
894,92 tis.
52-tjed. najviša
17,88 SEK
52-tjed. najniža
0,90 SEK
EPS
−1,98 SEK
Dionice u optjecaju
134,00 mil.
Broj djelatnika
42
Otvori
0,95 SEK
Najviša
0,99 SEK
Najniža
0,92 SEK
Trž. kap.
148,45 mil.
Prosj. kol.
759,33 tis.
Količina
894,92 tis.
52-tjed. najviša
17,88 SEK
52-tjed. najniža
0,90 SEK
EPS
−1,98 SEK
Dionice u optjecaju
134,00 mil.
Broj djelatnika
42
Vijesti
Iz web-izvora i od partnera za vijesti
hr.bloombergadria.com
·
prije 2 dana
Trump slavi rekorde na Wall Streetu, ali iza burzovne euforije krije se opasna istina
StreetInsider
·
prije 1 sat
XRP News Today: Nasdaq Exposure Could Transform XRP as Remittix Targets Everyday Payment Adoption
Mitrade
·
prije 49 minuta
XRP’s Nasdaq Moment Nears: 5 Things to Know About Evernorth
Barchart.com
·
prije 4 sata
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Profil
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
Diamyd Medical AB – informacije